Unimicron Technology (3037) Q3 2025 earnings summary

Executive summary

• Q3 2025 net sales reached NT$33,994M, up 4.7% sequentially and 12.3% year-over-year for the first nine months of 2025.

• Revenue for the nine months ended September 30, 2025, was NT$96.55 billion, up 12% year-over-year, with net income at NT$3.14 billion, a 38% decrease from the prior year period.

• Net income for Q3 2025 was NT$2,451M, a significant increase from NT$260M in Q2 2025.

• Gross margin improved to 13.4% in Q3 2025 from 13.1% in Q2 2025, but for the nine months was 13%, down from 15% year-over-year.

• Earnings per share for the nine months were NT$2.06 (basic) and NT$2.05 (diluted), compared to NT$3.30 and NT$3.28, respectively, in the prior year.

Financial highlights

• Q3 2025 EBITDA was NT$7,900M (23% of sales), with EPS (basic) at NT$1.44.

• For Q1–Q3 2025, net income was NT$3,635M, down 34% year-over-year.

• Q1–Q3 2025 EBITDA totaled NT$19,258M (20% of sales), with basic EPS at NT$2.06.

• Cash and cash equivalents at end of Q3 2025 were NT$42,832M.

• Capital expenditures for property, plant, and equipment were NT$20.00 billion for the nine months.

Outlook and guidance

• The Board resolved to issue new convertible bonds and a cash capital increase to repay maturing bonds and strengthen operating capital.

• Plans are underway for a subsidiary to apply for listing on the Hong Kong Stock Exchange to enhance global competitiveness.

• Forward-looking statements highlight risks and uncertainties that may impact future performance.